Ulrik Schulze leads Boston Consulting Group’s biopharmaceuticals sector and is a member of the Health Care practice in Switzerland. He is a member of the firm’s Marketing, Sales & Pricing, Operations, Corporate Development, People & Organization, and Strategy practices.

Since joining BCG in 1997, Ulrik has worked intensively with clients in the pharmaceutical, biotechnology, medtech, and private-equity sectors in the US, Europe, and Asia. He has worked globally with management teams of leading global companies as well as ambitious emerging companies and private equity firms. His experience covers the full value chain from R&D and manufacturing to commercial, business development and capital market strategies.

Ulrik’s work has more recently focused on strategy development, M&A, post-merger integration as well as organizational and operational transformations. His experience in corporate strategy includes acquisitions, integrations, licensing, and alignment of strategy with value creation for shareholders.

Before joining BCG, Ulrik worked as a postdoctoral fellow in the chemical engineering and biology departments at the Massachusetts Institute of Technology.